(SLDE) Slide Insurance Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8313491057
Stock:
Total Rating 57
Risk 81
Buy Signal 2.36
| Risk 5d forecast | |
|---|---|
| Volatility | 81.0% |
| Relative Tail Risk | -14.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.55 |
| Alpha | 5.42 |
| Character TTM | |
|---|---|
| Beta | 0.384 |
| Beta Downside | 0.504 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.32% |
| CAGR/Max DD | 0.49 |
EPS (Earnings per Share)
Revenue
Description: SLDE Slide Insurance Holdings
Slide Insurance Holdings, Inc. engages in underwriting single family and condominium policies in the property and casualty industry in the United States. It writes coastal specialty personal lines insurance, including homeowners, condominium unit owners, commercial residential, and other products, as well as reinsurance products. The company was incorporated in 2021 and is headquartered in Tampa, Florida.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 348.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA -13.22 > 1.0 |
| NWC/Revenue: 153.5% < 20% (prev 80.89%; Δ 72.57% < -1%) |
| CFO/TA 0.20 > 3% & CFO 534.2m > Net Income 348.7m |
| Net Debt (-816.6m) to EBITDA (483.6m): -1.69 < 3 |
| Current Ratio: 46.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (140.1m) vs 12m ago 12.15% < -2% |
| Gross Margin: 62.42% > 18% (prev 0.45%; Δ 6196 % > 0.5%) |
| Asset Turnover: 48.47% > 50% (prev 46.62%; Δ 1.85% > 0%) |
| Interest Coverage Ratio: 133.7 > 6 (EBITDA TTM 483.6m / Interest Expense TTM 3.53m) |
Altman Z'' 6.59
| A: 0.60 (Total Current Assets 1.64b - Total Current Liabilities 35.1m) / Total Assets 2.69b |
| B: 0.22 (Retained Earnings 582.8m / Total Assets 2.69b) |
| C: 0.22 (EBIT TTM 471.5m / Avg Total Assets 2.16b) |
| D: 0.47 (Book Value of Equity 590.8m / Total Liabilities 1.27b) |
| Altman-Z'' Score: 6.59 = AAA |
Beneish M -2.68
| DSRI: 1.75 (Receivables 352.8m/147.0m, Revenue 1.05b/762.2m) |
| GMI: 0.73 (GM 62.42% / 45.49%) |
| AQI: 0.62 (AQ_t 0.38 / AQ_t-1 0.61) |
| SGI: 1.37 (Revenue 1.05b / 762.2m) |
| TATA: -0.07 (NI 348.7m - CFO 534.2m) / TA 2.69b) |
| Beneish M-Score: -2.68 (Cap -4..+1) = A |
What is the price of SLDE shares?
As of February 26, 2026, the stock is trading at USD 19.49 with a total of 6,046,055 shares traded.
Over the past week, the price has changed by +15.33%, over one month by +23.12%, over three months by +15.33% and over the past year by +14.65%.
Over the past week, the price has changed by +15.33%, over one month by +23.12%, over three months by +15.33% and over the past year by +14.65%.
Is SLDE a buy, sell or hold?
Slide Insurance Holdings has no consensus analysts rating.
What are the forecasts/targets for the SLDE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23 | 18% |
| Analysts Target Price | 23 | 18% |
SLDE Fundamental Data Overview February 26, 2026
P/E Trailing = 6.3238
P/S = 2.1293
P/B = 2.1296
Revenue TTM = 1.05b USD
EBIT TTM = 471.5m USD
EBITDA TTM = 483.6m USD
Long Term Debt = 35.0m USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last fiscal year)
Debt = 45.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -816.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.37b USD (2.23b + Debt 45.0m - CCE 903.2m)
Interest Coverage Ratio = 133.7 (Ebit TTM 471.5m / Interest Expense TTM 3.53m)
EV/FCF = 2.58x (Enterprise Value 1.37b / FCF TTM 531.1m)
FCF Yield = 38.71% (FCF TTM 531.1m / Enterprise Value 1.37b)
FCF Margin = 50.71% (FCF TTM 531.1m / Revenue TTM 1.05b)
Net Margin = 33.29% (Net Income TTM 348.7m / Revenue TTM 1.05b)
Gross Margin = 62.42% ((Revenue TTM 1.05b - Cost of Revenue TTM 393.6m) / Revenue TTM)
Gross Margin QoQ = 73.79% (prev 52.81%)
Tobins Q-Ratio = 0.51 (Enterprise Value 1.37b / Total Assets 2.69b)
Interest Expense / Debt = 2.02% (Interest Expense 909.0k / Debt 45.0m)
Taxrate = 24.50% (36.0m / 147.0m)
NOPAT = 356.0m (EBIT 471.5m * (1 - 24.50%))
Current Ratio = 46.76 (Total Current Assets 1.64b / Total Current Liabilities 35.1m)
Debt / Equity = 0.05 (Debt 45.0m / totalStockholderEquity, last quarter 964.2m)
Debt / EBITDA = -1.69 (Net Debt -816.6m / EBITDA 483.6m)
Debt / FCF = -1.54 (Net Debt -816.6m / FCF TTM 531.1m)
Total Stockholder Equity = 699.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.14% (Net Income 348.7m / Total Assets 2.69b)
RoE = 49.85% (Net Income TTM 348.7m / Total Stockholder Equity 699.5m)
RoCE = 64.20% (EBIT 471.5m / Capital Employed (Equity 699.5m + L.T.Debt 35.0m))
RoIC = 48.34% (NOPAT 356.0m / Invested Capital 736.4m)
WACC = 7.22% (E(2.23b)/V(2.28b) * Re(7.33%) + D(45.0m)/V(2.28b) * Rd(2.02%) * (1-Tc(0.24)))
Discount Rate = 7.33% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 5.90%
[DCF] Terminal Value 80.95% ; FCFF base≈534.4m ; Y1≈530.1m ; Y5≈552.2m
[DCF] Fair Price = 98.94 (EV 11.48b - Net Debt -816.6m = Equity 12.30b / Shares 124.3m; r=7.22% [WACC]; 5y FCF grow -1.54% → 2.90% )
EPS Correlation: 72.66 | EPS CAGR: 93.40% | SUE: N/A | # QB: 0
Revenue Correlation: 93.54 | Revenue CAGR: 44.66% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.72 | Chg7d=+0.015 | Chg30d=+0.042 | Revisions Net=+3 | Analysts=4
EPS current Year (2026-12-31): EPS=2.90 | Chg7d=+0.000 | Chg30d=+0.010 | Revisions Net=+5 | Growth EPS=-13.8% | Growth Revenue=+13.6%
EPS next Year (2027-12-31): EPS=2.84 | Chg7d=-0.020 | Chg30d=-0.003 | Revisions Net=+0 | Growth EPS=-1.9% | Growth Revenue=+5.7%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -7.9% (Discount Rate 7.9% - Earnings Yield 15.8%)
[Growth] Growth Spread = +7.9% (Analyst 0.0% - Implied -7.9%)
P/S = 2.1293
P/B = 2.1296
Revenue TTM = 1.05b USD
EBIT TTM = 471.5m USD
EBITDA TTM = 483.6m USD
Long Term Debt = 35.0m USD (from longTermDebt, last quarter)
Short Term Debt = 6.00m USD (from shortTermDebt, last fiscal year)
Debt = 45.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -816.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.37b USD (2.23b + Debt 45.0m - CCE 903.2m)
Interest Coverage Ratio = 133.7 (Ebit TTM 471.5m / Interest Expense TTM 3.53m)
EV/FCF = 2.58x (Enterprise Value 1.37b / FCF TTM 531.1m)
FCF Yield = 38.71% (FCF TTM 531.1m / Enterprise Value 1.37b)
FCF Margin = 50.71% (FCF TTM 531.1m / Revenue TTM 1.05b)
Net Margin = 33.29% (Net Income TTM 348.7m / Revenue TTM 1.05b)
Gross Margin = 62.42% ((Revenue TTM 1.05b - Cost of Revenue TTM 393.6m) / Revenue TTM)
Gross Margin QoQ = 73.79% (prev 52.81%)
Tobins Q-Ratio = 0.51 (Enterprise Value 1.37b / Total Assets 2.69b)
Interest Expense / Debt = 2.02% (Interest Expense 909.0k / Debt 45.0m)
Taxrate = 24.50% (36.0m / 147.0m)
NOPAT = 356.0m (EBIT 471.5m * (1 - 24.50%))
Current Ratio = 46.76 (Total Current Assets 1.64b / Total Current Liabilities 35.1m)
Debt / Equity = 0.05 (Debt 45.0m / totalStockholderEquity, last quarter 964.2m)
Debt / EBITDA = -1.69 (Net Debt -816.6m / EBITDA 483.6m)
Debt / FCF = -1.54 (Net Debt -816.6m / FCF TTM 531.1m)
Total Stockholder Equity = 699.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 16.14% (Net Income 348.7m / Total Assets 2.69b)
RoE = 49.85% (Net Income TTM 348.7m / Total Stockholder Equity 699.5m)
RoCE = 64.20% (EBIT 471.5m / Capital Employed (Equity 699.5m + L.T.Debt 35.0m))
RoIC = 48.34% (NOPAT 356.0m / Invested Capital 736.4m)
WACC = 7.22% (E(2.23b)/V(2.28b) * Re(7.33%) + D(45.0m)/V(2.28b) * Rd(2.02%) * (1-Tc(0.24)))
Discount Rate = 7.33% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 5.90%
[DCF] Terminal Value 80.95% ; FCFF base≈534.4m ; Y1≈530.1m ; Y5≈552.2m
[DCF] Fair Price = 98.94 (EV 11.48b - Net Debt -816.6m = Equity 12.30b / Shares 124.3m; r=7.22% [WACC]; 5y FCF grow -1.54% → 2.90% )
EPS Correlation: 72.66 | EPS CAGR: 93.40% | SUE: N/A | # QB: 0
Revenue Correlation: 93.54 | Revenue CAGR: 44.66% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.72 | Chg7d=+0.015 | Chg30d=+0.042 | Revisions Net=+3 | Analysts=4
EPS current Year (2026-12-31): EPS=2.90 | Chg7d=+0.000 | Chg30d=+0.010 | Revisions Net=+5 | Growth EPS=-13.8% | Growth Revenue=+13.6%
EPS next Year (2027-12-31): EPS=2.84 | Chg7d=-0.020 | Chg30d=-0.003 | Revisions Net=+0 | Growth EPS=-1.9% | Growth Revenue=+5.7%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -7.9% (Discount Rate 7.9% - Earnings Yield 15.8%)
[Growth] Growth Spread = +7.9% (Analyst 0.0% - Implied -7.9%)